Lactose (India) Limited (BOM:524202)
100.00
-1.50 (-1.48%)
At close: Aug 21, 2026
Lactose (India) Revenue
Lactose (India) had revenue of 469.68M INR in the quarter ending June 30, 2026, with 18.68% growth. This brings the company's revenue in the last twelve months to 1.71B, up 34.91% year-over-year. In the fiscal year ending March 31, 2026, Lactose (India) had annual revenue of 1.63B with 40.28% growth.
Revenue (ttm)
1.71B
Revenue Growth
+34.91%
P/S Ratio
0.74
Revenue / Employee
12.19M
Employees
140
Market Cap
1.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.63B | 468.91M | 40.28% |
| Mar 31, 2025 | 1.16B | 25.10M | 2.20% |
| Mar 31, 2024 | 1.14B | 480.94M | 73.09% |
| Mar 31, 2023 | 657.96M | 198.57M | 43.23% |
| Mar 31, 2022 | 459.39M | 109.76M | 31.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 3.34B |
| Parnax Lab | 2.52B |
| Sat Kartar Life | 2.01B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Concord Drugs | 860.69M |
| Speciality Medicines | 752.85M |
| Mercury Laboratories | 737.65M |